G protein-coupled and ATP-sensitive inwardly rectifying potassium ion channels are essential for HIV entry

被引:12
作者
Dubey, Ravi C. [1 ]
Mishra, Nawneet [1 ]
Gaur, Ritu [1 ]
机构
[1] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi 110021, India
关键词
VIROPORINS STRUCTURE; K+ CHANNELS; HOST-CELL; MEMBRANE; GLIBENCLAMIDE; MODULATION; INFECTION; MECHANISM; PEPTIDE; TARGETS;
D O I
10.1038/s41598-019-40968-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The high genetic diversity of Human Immunodeficiency virus (HIV), has hindered the development of effective vaccines or antiviral drugs against it. Hence, there is a continuous need for identification of new antiviral targets. HIV exploits specific host proteins also known as HIV-dependency factors during its replication inside the cell. Potassium channels play a crucial role in the life cycle of several viruses by modulating ion homeostasis, cell signaling, cell cycle, and cell death. In this study, using pharmacological tools, we have identified that HIV utilizes distinct cellular potassium channels at various steps in its life cycle. Members of inwardly rectifying potassium (K-ir) channel family, G protein-coupled (GIRK), and ATP-sensitive (K-ATP) are involved in HIV entry. Blocking these channels using specific inhibitors reduces HIV entry. Another member, K-ir 1.1 plays a role post entry as inhibiting this channel inhibits virus production and release. These inhibitors are not toxic to the cells at the concentration used in the study. We have further identified the possible mechanism through which these potassium channels regulate HIV entry by using a slow-response potential-sensitive probe DIBAC4(3) and have observed that blocking these potassium channels inhibits membrane depolarization which then inhibits HIV entry and virus release as well. These results demonstrate for the first time, the important role of K-ir channel members in HIV-1 infection and suggest that these K+ channels could serve as a safe therapeutic target for treatment of HIV/AIDS.
引用
收藏
页数:9
相关论文
共 51 条
[1]   HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth [J].
Acharya, Priyamvada ;
Lusvarghi, Sabrina ;
Bewley, Carole A. ;
Kwong, Peter D. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (06) :765-783
[2]   Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics [J].
Albin, John S. ;
Harris, Reuben S. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2010, 12
[3]   HIV-1 Antiretroviral Drug Therapy [J].
Arts, Eric J. ;
Hazuda, Daria J. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04)
[4]   Ion Channels as Therapeutic Targets: A Drug Discovery Perspective [J].
Bagal, Sharan ;
Brown, Alan D. ;
Cox, Peter J. ;
Omoto, Kiyoyuki ;
Owen, Robert M. ;
Pryde, David C. ;
Sidders, Benjamin ;
Skerratt, Sarah E. ;
Stevens, Edward B. ;
Storer, R. Ian ;
Swain, Nigel A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) :593-624
[5]   Human Rhinovirus Type 2 Uncoating at the Plasma Membrane Is Not Affected by a pH Gradient but Is Affected by the Membrane Potential [J].
Berka, Ursula ;
Khan, Abdul ;
Blaas, Dieter ;
Fuchs, Renate .
JOURNAL OF VIROLOGY, 2009, 83 (08) :3778-3787
[6]   Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy [J].
Bhatti, Adnan Bashir ;
Usman, Muhammad ;
Kandi, Venkataramana .
CUREUS, 2016, 8 (03)
[7]  
Biasiotto R., 2010, THEP13 PROTEIN HUMAN, DOI [10.1016/j.bbabio.2010.02.023, DOI 10.1016/J.BBABIO.2010.02.023]
[8]  
Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
[9]   HIV entry inhibitors: mechanisms of action and resistance pathways [J].
Briz, V ;
Poveda, E ;
Soriano, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :619-627
[10]   HIV-GP120 ACTIVATES LARGE-CONDUCTANCE APAMIN-SENSITIVE POTASSIUM CHANNELS IN RAT ASTROCYTES [J].
BUBIEN, JK ;
BENVENISTE, EN ;
BENOS, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 268 (06) :C1440-C1449